Nivolumab and Ipilimumab and Radiation Therapy in MSS and MSI High Colorectal and Pancreatic Cancer

NCT03104439 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

84

Enrollment

OTHER

Sponsor class

Conditions

Microsatellite Stable Colorectal Cancer
Pancreatic Cancer
MSI High Colorectal Cancer

Interventions

DRUG: Nivolumab
DRUG: Ipilimumab
RADIATION: Radiation Therapy

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]